Synth-Med Biotechnology enables precision drug delivery to hard-to-reach areas like the brain and tumors by using engineered human blood. This approach overcomes barriers such as the blood-brain barrier to deliver medicine directly to disease sites. The mission is to revolutionize treatment for conditions like Alzheimer’s disease and prostate cancer, saving lives through targeted, effective therapies.